| Literature DB >> 25083370 |
Yu Teranishi1, Michihiro Kohno1, Shigeo Sora1, Hiroaki Sato1, Munehiro Yokoyama2.
Abstract
Cavernous sinus angioleiomyoma (ALM) is extremely rare. Only three cases have been reported to be cavernous sinus ALM, and very few reports described characteristic findings for intracranial ALMs in detail. We report a new case of cavernous sinus ALM, with detailed information on the clinical presentation, radiology, pathology, and surgical approach. A 52-year-old woman had a 6-month history of right eye discomfort. Magnetic resonance imaging showed a right cavernous sinus tumor with heterogenous blush enhancement. Enhanced computed tomography scans and angiography showed small nodular enhancement in the tumor. Complete tumor resection was achieved via an extradural temporopolar approach. ALM was identified based on histologic examination. Intracranial ALMs are different from the ALMs that occur in the extremities based on our review of the literature. Intracranial ALMs appear more frequently in men than women. The cavernous type was the most common pathologically, and they occur often in the epiperidural location. Because cavernous sinus ALM occurs in the interdural space, an epidural approach should be selected. Therefore, it is important to include cavernous sinus ALM into a differential diagnosis of a cavernous sinus tumor. The blush enhancement and nodular enhancement within this lesion may be useful to distinguish cavernous sinus ALM from other differential diagnoses.Entities:
Keywords: angioleiomyoma; cavernous sinus; hemangioma
Year: 2014 PMID: 25083370 PMCID: PMC4110136 DOI: 10.1055/s-0034-1376425
Source DB: PubMed Journal: J Neurol Surg Rep ISSN: 2193-6358
Fig. 1Preoperative magnetic resonance imaging findings. (A) Axial T1: The lesion showed isointensity. (B) Contrast-enhanced axial T1: The lesion showed heterogenous enhancement. (C) Axial T2: The lesion showed hyperintensity. (D) Axial diffusion-weighted image: The lesion showed hypointensity. (E) Coronal constructive interference in a steady state: The lesion revealed that the tumor was located between the layers of the lateral wall of the cavernous sinus. Note the tumor (circle).
Fig. 2Pathologic findings. (A–C) Dilated vascular channels intermingled with smooth muscle bundles (hematoxylin and eosin, ×100, ×400). (D) Endothelial cells showing strong positivity for CD34 (immunohistochemistry, ×400). (E–G) Smooth muscle bundles showing strong positivity for Calponin, h-Caldesmon, and αSMA (immunohistochemistry, ×400). (H) Ki-67 index was 2.1%.
Fig. 3Postoperative neuroradiologic findings. (A) T1-weighted magnetic resonance (MR) images. (B) Contrast-enhanced T1-weighted MR images. (C) Computed tomography scans.
Clinical findings of previous reports
| Age, y | Sex | Location | Size, mm | Symptoms | Duration of symptoms, mo | Approach | Removal | |
|---|---|---|---|---|---|---|---|---|
| Lach et al8 | 47 | M | Parietal lobe | 20 | Gait abnormality, parkinsonism | 14 | NA | GTR |
| Ravikumar et al9 | 12 | F | Caudate nucleus | NA | Diplopia, headache, seizure | 1.5 | Frontal craniotomy | GTR |
| Kohan et al7 | NA | NA | IAM | NA | Hearing loss, tinnitus | NA | Retrosigmoid | GTR |
| Figueiredo et al2 | 52 | M | Cavernous sinus | 60 | Diplopia, headache, facial numbness, impaired visual acuity | 6 | Frontotemporal | GTR |
| Karagama et al6 | 47 | F | IAM | 1 | Sensorineural hearing loss | 12 | Translabyrinthine | GTR |
| Colnat-Coulbois et al1 | 50 | M | Cavernous sinus | NA | Headache, diplopia | NA | Frontotemporal, intradural | GTR |
| Vijayasaradhi et al12 | 10 | F | Frontal intradiploic space | 40 | Headache | 4 | NA | GTR |
| Gasco et al5 | 43 | M | Cerebellar lesion | 44 | Blurry vision, ataxia, headache | 12 | Suboccipital | GTR |
| Xu et al13 | 53 | M | Sella | NA | Headache, visual deterioration | 3 | NA | GTR |
| Conner et al | 42 | M | Tentorial incisura | 10 | Headache | 3 | Midline suboccipital | GTR |
| Conner et al | 36 | M | Falx cerebri | 25 | Headache, lightheadedness | 24 | Interhemispheric | STR |
| Zhou et al3 | 62 | M | Cavernous sinus | 37 | seizure | 0 | NA | GTR |
| Shinde et al10 | 60 | M | Putamen, hippocampus | 20 | Headache, seizure | 2 | None | Biopsy |
| Present case | 52 | F | Cavernous sinus | 23 | Eye discomfort | 6 | Extradural temporopolar | GTR |
Abbreviations: GTR, gross total resection; IAM, internal acoustic meatus; NA, not available; STR, subtotal resection.
Radiologic findings of previous reports
| Radiologic findings | |
|---|---|
| Lach et al8 | CT: Homogenous enhancement, no mass effect, large draining vein |
| Ravikumar et al9 | CT: Enhanced mural nodule |
| Kohan et al7 | NA |
| Figueiredo et al2 | CT: Homogeneous enhancement, bone erosion; MRI: T1, isointense; T2, hyperintense; Gd, homogeneous enhancement; IC/optic chiasm displacement |
| Karagama et al6 | MRI: T1, isointense; T2, hyperintense; Gd, homogeneous enhancement |
| Colnat-Coulbois et al1 | MRI: T1, isointense; T2, hyperintense; Gd, heterogeneous enhancement |
| Vijayasaradhi et al12 | NA |
| Gasco et al5 | CT: Hyperdense; MRI: T1, isointense; T2, hyperintense; Gd, homogeneous enhancement |
| Xu et al13 | MRI: T1, hypotense; T2, hyperintense |
| Conner et al | MRI: T2, hyperintense; Gd, punctate enhancement |
| Conner et al | CT: Homogeneous enhancement |
| Zhou et al3 | MRI: T1, isointense; T2, hyperintense; Gd, heterogeneous enhancement; DWI, hypointense |
| Shinde et al10 | MRI: T1, iso-hypointense; T2, hyperintense; Gd, homogeneous enhancement |
| Present case | MRI: T1, iso-hypointense; T2, hyperintense; Gd, heterogeneous enhancement; DWI, hypointense; CISS, hyperintense; enhanced CT: nodular tumor stains; angiography: nodular tumor stains |
Abbreviations: CISS, constructive interference in steady state; CT, computed tomography; DWI, diffusion-weighted image; Gd, gadolinium; IC, internal capsule; MRI, magnetic resonance image; NA, not available.
Pathologic findings of previous reports
| Pathologic findings | Type of ALM | |
|---|---|---|
| Lach et al8 | Vessel walls: desmin (+), vimentin (+), SMA (+), myosin (+) | Mixed |
| Ravikumar et al9 | Vessel walls: desmin (+), S100 (−), GFAP (−) | Solid |
| Kohan et al7 | NA | NA |
| Figueiredo et al2 | Vessel walls: vimentin (+), SMA (+), EMA (−), S100 (−), GFAP (−), MSA (−) | Cavernous |
| Karagama et al6 | Vessel walls: SMA(+) | Cavernous |
| Colnat-Coulbois et al1 | Vessel walls: vimentin (+), SMA (+), EMA (−), endothelial cells: CD31 (+), CD34 (+) | Cavernous |
| Vijayasaradhi et al12 | Vessel walls: SMA (+), EMA (−), vimentin (−), S100 (−) | Solid |
| Gasco et al5 | Vessel walls: SMA (+), endothelial cells only: CD34 (+), EMA (−), Ki-67 < 1% | Venous |
| Xu et al13 | Vessel walls: desmin (+), vimentin (+), SMA (+), MSA (+), AE1/AE3 (−), S100 (−), GFAP (−), EMA (+), endothelial cells: CD31 (+), CD34 (+) | Cavernous |
| Conner et al | Vessel walls: vimentin (+), SMA (+), MSA (+), endothelial cells: CD31 (+), CD34 (+), EMA (−), S100 (−) | Cavernous |
| Conner et al | Vessel walls: vimentin (+), SMA (+), MSA (+), endothelial cells: CD31 (+), CD34 (+), EMA (−), S100 (−) | Cavernous |
| Zhou et al3 | SMA (+), desmin (+), EMA (−), Ki-67 < 1% | Venous |
| Shinde et al10 | Vimentin (+), SMA (+), desmin (+), GFAP (−), EMA (−), Ki-67 (−) | NA |
| Present case | Endothelial cells: CD34 (+), spindle cell: αSMA (+), h-Caldesmon (+), calponin (+), EMA (−), S100 (−), CD34 (−) | Cavernous |
Abbreviations: AE1/AE3, antikeratin; EMA, epithelial membrane antigen; GFAP, glial fibrillary acidic protein; MSA, muscle-specific actin; NA, not available; SMA, smooth muscle actin.
Fig. 4Preoperative neuroradiologic findings. (A–C) Contrast-enhanced T1-weighted magnetic resonance images. (D) Enhanced computed tomography scans. (E) Preoperative cerebral angiography (right internal carotid angiography). Note the tumor (circle) with small labeled nodules within (arrow).